| 000 | 01321 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250515175659.0 | ||
| 264 | 0 | _c20090814 | |
| 008 | 200908s 0 0 eng d | ||
| 022 | _a1535-7228 | ||
| 024 | 7 |
_a10.1176/appi.ajp.2009.09040522 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWroblewska, Barbara | |
| 245 | 0 | 0 |
_aValidating novel targets for pharmacological interventions in schizophrenia. _h[electronic resource] |
| 260 |
_bThe American journal of psychiatry _cJul 2009 |
||
| 300 |
_a753-6 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aAntipsychotic Agents _xpharmacology |
| 650 | 0 | 4 |
_aBenzodiazepines _xpharmacology |
| 650 | 0 | 4 |
_aDrug Therapy _xmethods |
| 650 | 0 | 4 |
_aGTP-Binding Proteins _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aOlanzapine |
| 650 | 0 | 4 |
_aReceptors, GABA _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Glutamate _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Metabotropic Glutamate _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xdrug effects |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 700 | 1 | _aLewis, David A | |
| 773 | 0 |
_tThe American journal of psychiatry _gvol. 166 _gno. 7 _gp. 753-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1176/appi.ajp.2009.09040522 _zAvailable from publisher's website |
| 999 |
_c18987253 _d18987253 |
||